
Releases
B-Cell Depletion Therapy Market Projected to Reach USD 62.6 Billion by 2036
The global B-cell depletion therapy market is set for a decade of sustained expansion, with projections indicating a climb from USD 26.7 billion in 2026 to USD 62.6 billion by 2036. This growth, forecasted at a CAGR of 8.9%, reflects a shift toward targeted immunotherapies for complex autoimmune and hematologic conditions.

























